Region:Asia
Author(s):Rebecca
Product Code:KRAD8467
Pages:89
Published On:December 2025

By Application Type:The application type segmentation includes pre-exposure prophylaxis and post-exposure prophylaxis. Pre-exposure prophylaxis is primarily used for individuals at high risk of rabies exposure, such as veterinarians and animal handlers, while post-exposure prophylaxis is critical for those who have been bitten or exposed to potentially rabid animals. The increasing incidence of rabies cases in certain regions has led to a higher demand for both types of vaccines, with post-exposure prophylaxis currently dominating the market due to its urgent nature in preventing rabies after exposure.

By Route of Administration:The route of administration includes injectable vaccines and oral vaccines. Injectable vaccines are the most commonly used method for rabies vaccination due to their effectiveness and established protocols in veterinary practices. Oral vaccines, while less common, are gaining traction for their ease of administration, particularly in wildlife populations. The injectable segment currently leads the market, driven by its widespread acceptance and proven efficacy in both domestic and wild animals.

The ASEAN Rabies Veterinary Vaccines Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Virbac, Indian Immunologicals Ltd., BroadChem Philippines Biopharma Corporation contribute to innovation, geographic expansion, and service delivery in this space.
The future of the ASEAN rabies veterinary vaccines market appears promising, driven by increasing government support and public awareness initiatives. As vaccination programs expand, particularly in rural areas, the market is likely to see enhanced accessibility and affordability of vaccines. Additionally, technological advancements in vaccine development, such as oral vaccines, are expected to simplify administration and improve uptake rates. These trends indicate a proactive approach to rabies control, fostering a healthier environment for both animals and humans in the region.
| Segment | Sub-Segments |
|---|---|
| By Application Type | Pre-exposure Prophylaxis Post-exposure Prophylaxis |
| By Route of Administration | Injectable Vaccines Oral Vaccines |
| By End-User | Veterinary Hospitals and Clinics Animal Shelters and Rescue Organizations Research Institutes |
| By Distribution Channel | Hospital/Clinical Pharmacy Veterinary Pharmacies E-commerce Platforms Direct Sales |
| By Animal Type | Companion Animals (Dogs and Cats) Livestock Wildlife |
| By Vaccine Type | Inactivated Vaccines Live Attenuated Vaccines Recombinant Vaccines |
| By Geography | Indonesia Thailand Vietnam Malaysia Philippines Myanmar Cambodia Laos Rest of ASEAN |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Veterinary Clinics and Hospitals | 120 | Veterinarians, Clinic Managers |
| Animal Health Product Distributors | 100 | Sales Managers, Distribution Coordinators |
| Government Health Departments | 80 | Public Health Officials, Policy Makers |
| Research Institutions and Universities | 70 | Animal Health Researchers, Professors |
| Non-Governmental Organizations (NGOs) | 60 | Program Coordinators, Animal Welfare Advocates |
The ASEAN Rabies Veterinary Vaccines Market is valued at approximately USD 30 million, driven by increased awareness of rabies prevention, government vaccination initiatives, and rising pet ownership across the region.